Skip to main content

Advertisement

Log in

Altered IFN-γ Levels after Treatment of Epileptic Patients with Omega-3 Fatty Acids

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Epilepsy is a frequent chronic disorder of the brain characterized by intermittent epileptic seizures caused by hypersynchronous discharge of neurons in the brain. Studies have reported the role of cytokines in the pathogenesis of epilepsy, and a number of investigations have shown decreased levels of omega-3 fatty acids in epileptic patients. We investigated differences in serum levels of two cytokines, transforming growth factor (TGF)-β and interferon (IFN)-γ, in 40 epileptic cases prior to and after treatment with omega-3 fatty acids. IFN-γ levels were significantly increased after the 16-week treatment period (P < 0.001). However, TGF-β levels remained unchanged (P = 0.14). Omega-3 fatty acid treatment may alter the immune response in epileptic patients. This should be considered in prescription of omega-3 fatty acid supplements in these patients. Future studies with larger sample sizes should verify the results of the current study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data Availability

The data sets generated and analyzed during the study are available from the corresponding author on reasonable request.

References

  • Aronica E, van Vliet EA, Mayboroda OA, Troost D, da Silva FH, Gorter JA (2000) Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur J Neurosci 12:2333–2344

    Article  CAS  Google Scholar 

  • Bromfield E, Dworetzky B, Hurwitz S, Eluri Z, Lane L, Replansky S, Mostofsky D (2008) A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Behav 12:187–190

    Google Scholar 

  • Chandrasekar B, Troyer DA, Venkatraman JT, Fernandes G (1995) Dietary omega-3 lipids delay the onset and progression of autoimmune lupus nephritis by inhibiting transforming growth factor beta mRNA and protein expression. J Autoimmun 8:381–393

    Article  CAS  Google Scholar 

  • Degiorgio CM, Miller PR, Harper R, Gornbein J, Schrader L, Soss J, Meymandi S (2015) Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study. J Neurol Neurosurg Psychiatry 86:65–70

    Article  Google Scholar 

  • Degiorgio CM, Scorza FA (2014) Epilepsy & behavior: 15th anniversary research on omega-3 fatty acids for epilepsy. Behav 40:124–125

    Google Scholar 

  • Feng C, Keisler DH, Fritsche KL (1999) Dietary omega-3 polyunsaturated fatty acids reduce IFN-gamma receptor expression in mice. J Interferon Cytokine Res 19:41–48

    Article  CAS  Google Scholar 

  • Fernandes G, Bysani C, Venkatraman JT, Tomar V, Zhao W (1994) Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice. J Immunol 152:5979–5987

    CAS  PubMed  Google Scholar 

  • Kang JX, Weylandt KH (2008) Modulation of inflammatory cytokines by omega-3 fatty acids. Subcell Biochem 49:133–143

    Article  Google Scholar 

  • Li G, Bauer S, Nowak M, Norwood B, Tackenberg B, Rosenow F, Knake S, Oertel WH, Hamer HM (2011) Cytokines and epilepsy. Seizure 20:249–256

    Article  Google Scholar 

  • Li T, Zhai X, Jiang J, Song X, Han W, Ma J, Xie L, Cheng L, Chen H, Jiang L (2017) Intraperitoneal injection of IL-4/IFN-gamma modulates the proportions of microglial phenotypes and improves epilepsy outcomes in a pilocarpine model of acquired epilepsy. Brain Res 1657:120–129

    Article  CAS  Google Scholar 

  • McNamara RK, Carlson SE (2006) Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 75:329–349

    Article  CAS  Google Scholar 

  • Omrani S, Taheri M, Omrani MD, Arsang-Jang S, Ghafouri-Fard S (2019) The effect of omega-3 fatty acids on clinical and paraclinical features of intractable epileptic patients: a triple blind randomized clinical trial. Clin Transl Med 8:3

    Article  Google Scholar 

  • Plata-Salaman CR, Ilyin SE, Turrin NP, Gayle D, Flynn MC, Romanovitch AE, Kelly ME, Bureau Y, Anisman H, McIntyre DC (2000) Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions. Brain Res Mol Brain Res 75:248–258

    Article  CAS  Google Scholar 

  • Pourmasoumi M, Vosoughi N, Derakhshandeh-Rishehri SM, Assarroudi M, Heidari-Beni M (2018) Association of Omega-3 Fatty Acid and Epileptic Seizure in Epileptic Patients: A Systematic Review. Int J Prev Med 9:36

    Article  Google Scholar 

  • Sharma A, Belna J, Espat J, Rodriguez G, Cannon VT, Hurteau JA (2009) Effects of omega-3 fatty acids on components of the transforming growth factor beta-1 pathway: implication for dietary modification and prevention in ovarian cancer. Am J Obstet Gynecol 200(516):e1-6

    Google Scholar 

  • Sinha S, Patil SA, Jayalekshmy V, Satishchandra P (2008) Do cytokines have any role in epilepsy? Epilepsy Res 82:171–176

    Article  CAS  Google Scholar 

  • Sonar SA, Shaikh S, Joshi N, Atre AN, Lal G (2017) IFN-gamma promotes transendothelial migration of CD4(+) T cells across the blood-brain barrier. Immunol Cell Biol 95:843–853

    Article  CAS  Google Scholar 

  • Stafstrom CE, Carmant L (2015) Seizures and epilepsy: an overview for neuroscientists. Cold Spring Harb Perspect Med 5

  • Tejada S, Martorell M, Capo X, Tur JA, Pons A, Sureda A (2016) Omega-3 Fatty Acids in the Management of Epilepsy. Curr Top Med Chem 16:1897–1905

    Article  CAS  Google Scholar 

  • Zack MM, Kobau R (2017) National and state estimates of the numbers of adults and children with active epilepsy—United States, 2015. MMWR Morb Mortal Wkly Rep 66:821

    Article  Google Scholar 

Download references

Funding

This study was financially supported by Shahid Beheshti University of Medical Sciences.

Author information

Authors and Affiliations

Authors

Contributions

SGF and MT wrote the manuscript and revised it. MAO and MH analyzed the data. AS, MR and BMH performed the experiment and designed the tables. All authors approved the final manuscript.

Corresponding authors

Correspondence to Arezou Sayad or Mohammad Taheri.

Ethics declarations

Ethics Approval and Consent to Participate

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent forms were obtained from all study participants. The study protocol was approved by the ethical committee of Shahid Beheshti University of Medical Sciences (IR.SBMU.MSP.REC.1397.544). All methods were performed in accordance with the relevant guidelines and regulations.

Competing Interests

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghafouri-Fard, S., Hashemi, M., Rafigh, M. et al. Altered IFN-γ Levels after Treatment of Epileptic Patients with Omega-3 Fatty Acids. J Mol Neurosci 71, 2364–2367 (2021). https://doi.org/10.1007/s12031-021-01804-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-021-01804-y

Keywords

Navigation